Table 2.

Initial EPO dosages of patients with or without VA eventsa

AccessWith VA EventsWithout VA EventsP
Global122.9 (76.4)111.5 (70.8)0.031
Native AVF113.8 (70.6)110.6 (71.2)NS
PTFE Graft131.1 (87.6)116.0 (72.4)NS
Catheter135.3 (76.2)124.2 (65.2)NS
  • a Data for subgroups according to type of vascular access and comparisons between subgroups according (ANOVA). Data are means (SD) in U/kg per wk (patients with complete follow-up n =1328).